Ascariasis in a 75-year-old man with small bowel volvulus: a case report

Background: Ascaris lumbricoides and Ascaris suum are the most common soil-transmitted helminths of humans and pigs, respectively. The zoonotic potential of A. suum has been a matter of debate for decades. This study was aimed to present a case of human ascariasis caused by A. suum in southern Italy. Case presentation: A 75-year-old man presented to the department of surgery in Avellino (southern Italy) complaining of abdominal pain and vomiting. Physical examination revealed bloating and abdominal tenderness. A computed tomography scan showed air-fluid levels and small bowel distension. During exploratory laparotomy a small bowel volvulus with mesenteritis was evident and surprisingly an intraluminal worm was detected. The worm was removed with a small enterotomy and identified as an adult female of A. suum based on morphological and molecular analysis. Faecal examination revealed the presence of unfertilized Ascaris eggs with an intensity of 16 eggs per gram (EPG) of faeces. The patient was treated with mebendanzole 100 mg twice a day for 3 days. The post-operative course was regular with re-alimentation after 3 days and discharge after 12 days. Conclusions: This report shows as A. suum can function as a relevant agent of human zoonosis. Therefore, in patients with bowel obstruction with no evident aetiology a helminthic infestation should be considered for an accurate diagnosis, especially in patients living in rural areas.Fil: Romano, Giovanni. Frieri-Criscuoli Hospital; ItaliaFil: Pepe, Paola. Università degli Studi di Napoli Federico II; ItaliaFil: Cavallero, Serena. Università di Roma; ItaliaFil: Cociancic, Paola. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Estudios Parasitológicos y de Vectores. Universidad Nacional de La Plata. Facultad de Ciencias Naturales y Museo. Centro de Estudios Parasitológicos y de Vectores; ArgentinaFil: Di Libero, Lorenzo. Frieri-Criscuoli Hospital; ItaliaFil: Grande, Giovanni. Frieri-Criscuoli Hospital; ItaliaFil: Cringoli, Giuseppe. Università degli Studi di Napoli Federico II; ItaliaFil: D'Amelio, Stefano. Università di Roma; ItaliaFil: Rinaldi, Laura. Università degli Studi di Napoli Federico II; Itali

Quality of life, compliance, safety and effectiveness in fit older metastatic colorectal patients with cancer treated in first-line with chemotherapy plus cetuximab: A restrospective analysis from the ObservEr study

Abstract Objectives The influence of age ( KRAS wild type (WT) metastatic colorectal cancer (mCRC). Methods 225 patients of the Observed study (PS 0-1) were retrieved based on age ( Results The two patient groups (141  p  = 0.002), which is likely due to higher proportions of metastatic resection (27.0% vs 8.3%; p  = 0.001) and utilization of second-line therapy in younger group (58.9% vs 42.9%; p  = 0.028). Conclusion The current data suggest that fit older patients with mCRC can be safely treated with a cetuximab-based therapy, as QoL and safety profile do not seem to be affected by age. In addition, age did not impact the choice of chemotherapy to be associated to cetuximab and treatment compliance

Case Report Cat Scratch Disease Presenting as Breast Cancer: A Report of an Unusual Case

Benign lymphoreticulosis (cat scratch disease, CSD) may have a clinical course that varies from the most common lymphadenitis localized in the site of inoculation, preceded by the typical "primary lesion, " to a context of severe systemic involvement. Among these uncommon clinical aspects, there is mammarian granulomatous lymphadenitis which may appear as a mastitis or a solitary intraparenchymal mass, giving the impression of a breast tumor. In these cases, intensive clinical, instrumental, and laboratory investigations are necessary to exclude malignancy. Because of its rarity, in equivocal cases, it is reasonable to use surgical excision for accurate histological examination. We report a case of CSD of the breast in a 59-year-old woman, analyzing the clinical, histopathological, and instrumental appearance and also performing a literature review

Cat Scratch Disease Presenting as Breast Cancer: A Report of an Unusual Case

Benign lymphoreticulosis (cat scratch disease, CSD) may have a clinical course that varies from the most common lymphadenitis localized in the site of inoculation, preceded by the typical “primary lesion,” to a context of severe systemic involvement. Among these uncommon clinical aspects, there is mammarian granulomatous lymphadenitis which may appear as a mastitis or a solitary intraparenchymal mass, giving the impression of a breast tumor. In these cases, intensive clinical, instrumental, and laboratory investigations are necessary to exclude malignancy. Because of its rarity, in equivocal cases, it is reasonable to use surgical excision for accurate histological examination. We report a case of CSD of the breast in a 59-year-old woman, analyzing the clinical, histopathological, and instrumental appearance and also performing a literature review

Predictors of outcome in an AIEOP series of childhood ependymomas: a multifactorial analysis

Several molecular biomarkers have been suggested as predictors of outcome for pediatric ependymomas but deserve further validation in independent case series. We analyzed intracranial ependymomas belonging to a series of 60 patients prospectively treated according to the protocol sponsored by the Italian Association of Pediatric Hematology-Oncology. We used a tissue microarray to analyze nucleolin (NCL), cyclin-dependent kinase inhibitor 2A (CDKN2A), tumor protein 53 (TP53), and epidermal growth factor receptor (EGFR) by immunohistochemistry and by 1q gain by fluorescent in situ hybridization. The mRNA expression levels of EGFR, human telomerase reverse-transcriptase (HTERT), and Prominin 1 (PROM 1)/CD133 were evaluated by quantitative real-time PCR from cases with fresh-frozen tumor material available. Univariate and multivariate analyses of updated clinical data confirmed the prognostic significance of surgery (P .01) and tumor grading (P .05) for both relapse-free survival (RFS) and overall survival (OS). Among biomolecular markers, HTERT mRNA expression emerged with the strongest association with OS at multivariate analysis (hazard ratio [HR] 9.9; P .011); the 5year OS was 84 versus 48 in the subgroups with HTERT median value 6 versus epsilon 6, respectively (P .005). Five-year RFS was 46 versus 20 in the subgroups with low versus high NCL protein expression, respectively (P .004), while multivariate Cox analyses gave suggestively high HRs for high versus low NCL (HR 1.9; P .090). The other genes tested were not significant at multivariate analyses, and genetic alterations of CDKN2A, TP53, EGFR, and HTERT loci were rare. The PROM1/CD133 cancer stem cell marker was strongly expressed at both RNA and protein levels in a substantial fraction of cases and was suggestively associated with a more indolent form of the disease. We conclude that NCL and HTERT represent the strongest prognostic biomarkers of RFS and OS, respectively, in our ependymoma case series

Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial

Abstract Background Platinum/fluoropyrimidine regimens are the backbone of first-line chemotherapy for advanced gastric cancer (AGC). However response rates to first line chemotherapy range from 30 to 50% and disease progression occurs after 4–6 cycles. The optimal duration of first-line therapy is still unknown and its continuation until disease progression represents the standard. However this strategy is often associated with cumulative toxicity and rapid development of drug resistance. Moreover, only about 40% of AGC pts. are eligible for second-line treatment. Methods This is a randomized, open-label, multicenter phase III trial. It aims at assessing whether switch maintenance to ramucirumab plus paclitaxel will extend the progression-free survival (PFS) of subjects with HER-2 negative AGC who have not progressed after 3 months of a first-line with a platinum/fluoropyrimidine regimen (either FOLFOX4, mFOLFOX6 or XELOX). The primary endpoint is to compare Progression-Free Survival (PFS) of patients in ARM A (switch maintenance to ramucirumab and placlitaxel) versus ARM B (continuation of the same first-line therapy with oxaliplatin/fluoropyrimidine). Secondary endpoints are: overall survival, time-to-treatment failure, overall response rate, duration of response, percentage of patients that will receive a second line therapy according to arm treatment, safety, quality of life. Exploratory studies including Next-Generation Sequencing (NGS) in archival tumor tissues are planned in order to identify potential biomarkers of primary resistance and prognosis. Discussion The ARMANI study estimates if patients treated with early swich with ramucirumab plus paclitaxel received benefit when compared to those treated with continuation of first line therapy. The hypothesis is that the early administration of an active, non-cross resistant second-line regimen such as ramucirumab plus paclitaxel may prolong the time in which patients are progression-free, and consequently have a better quality of life. Moreover, this strategy may rescue all those subjects that become ineligible for second-line therapy due to the rapid deterioration of health status after the first disease progression. Trial registration ARMANI is registered at ClinicalTrials.gov (NCT02934464, October 17, 2016) and EudraCT(2016–001783-12, April 202,016)

Apollo. A. 5(Gennaio 1965 - Dicembre 1984)

A. 5(gen.1965 - dic.1984): De Franciscis, A., Presentazione, P. 5 ; Panebianco, V., Ricordo di Antonio Marzullo, P. 7 ; Marzullo, B., Ricordo di Padre: Antonio Marzullo, P. 9 ; Gigante, M., Ricordo di Venturino Panebianco, P. 15 ; Nabers, N., A new hydria by the Pan Painter, P. 31 ; Trendall, A. D., A red-figured calyx-krater from Nocera, P. 47 ; Varone, A., Un miliario del Museo dell’Agro Nocerino e la via di Nocera al porto di Stabia (e al capo Ateneo), P. 59 ; Avagliano, G., Fratte di Salerno. Tomba VI/1971, P. 87 ; Fabbri, B., Guarino, D. P., e R. Maldera, Caratterizzazione tecnologica di un corredo ceramico della necropoli di Fratte, P. 95 ; Bignardi, M., Un ignoto salernitano della prima metà del quattrocento (l’affresco del vicolo dei Sediari), P. 127 ; Migliorini, P. M., La Certosa di Padula nella prima metà del ‘700 e le sue immagini, P. 133 ; D’Aniello, A., Contributo per la ricostruzione del disperso patrimonio della Certosa di S. Lorenzo diPadula, P. 145 ; Tamajo Contarini, M., Contributo alla conoscenza del patrimonio artistico della Certosa di Padula: il solimeniano Alessio D’Elia, P. 153 ; Samaritani, C., L’attività dei Musei Provinciali del Salernitano dal 1965 al 1984. P.165 ; Cipriani, M., Il Museo Archeologico Provinciale di Salerno, P. 183 ; Mangieri, G. L., Nota sulla Collezione Numismatica del Museo Archeologico Provinciale di S. Benedetto in Salerno, P. 187 ; Avagliano, G., La zona archeologica di Fratte, P. 191 ; Fiammenghi, C. A., Il Museo archeologico della Lucania Occidentale nella Certosa di Padula, P. 199 ; Varone, A., Il Museo dell’Agro Nocerino, P. 205 ; Iannelli, M. A., Il Museo della Ceramica Vietrese, P. 207 ; D’Andria, R., La sezione “Guido Gambone”: priorità di un’iniziativa, P. 215 ; Iacoe, A., La ceramica del Castello di Salerno, P. 221 ; Di Santo, A., Antiquarium di Sala Consilina, P. 223 ; Rota, L., Antiquarium di S. Marzano, P. 225 ; Falanga, L. Recenti contributi alla conoscenza di Salerno romana, P. 227 ; Compagnone, A., Profili storico della ceramica di Vietri, P. 249